← FDA Drug Approvals (Drugs@FDA)

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARM · Approved 2016-08-05

Drug application

FDA Application #

ANDA201633

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE

Generic name

BUPRENORPHINE AND NALOXONE

Active ingredients

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE

Dosage form

TABLET

Route

SUBLINGUAL

Marketing status

Prescription

Sponsor

SUN PHARM

Manufacturer

Sun Pharmaceutical Industries, Inc.

First approval

2016-08-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown